Share on LinkedInShare on LinkedIn

ARTICLE · 13 JULY 2020

Japanese Companies' Contribution Against COVID-19 By IPs

It is known that IP rights are used to challenge competitors so as to keep them in check or for the monopolizing technologies.

JapanIntellectual Property
Hirohisa Suzuki
Hirohisa Suzuki

Japanese Companies' Contribution against COVID-19 by IPs

It is known that IP rights are used to challenge competitors so as to keep them in check or for the monopolizing technologies. However, the current adverse situations caused by the COVID-19 pandemic have brought change to the way Japanese companies think. Through the need to develop and manufacture therapeutic medicines, vaccines, medical devices, infection prevention products to prevent the further spread of COVID-19 in the current situation through swift and unconventional ways, many Japanese companies have been taking actions to release their own patents under the “OPEN COVID-19 DECLARATION (OCD)” project.

There are 90 companies who have announced their involvement in the OCD and there are over 910,000 patents available for use (as of June 30, 2020) and the number is still increasing.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from